Literature DB >> 27430200

The safety and acceptability of Pipelle endometrial sampling in premenopausal women in comparison to postmenopausal women with abnormal uterine bleeding.

Mohamed Rezk1, Ragab Dawood, Alaa Masood.   

Abstract

BACKGROUND: The aim of this study was to assess the safety and acceptability of Pipelle endometrial sampling in premenopausal women in comparison to postmenopausal women.
METHODS: This was a prospective observational study including a total of 346 patients with abnormal uterine bleeding (AUB) who were divided into two groups, premenopausal group (N.=210) and postmenopausal group (N.=136). Primary outcome was safety and adequacy of Pipelle sampler. Secondary outcome included patients' acceptability.
RESULTS: Pain scores by Visual Analogue Scale were significantly higher in postmenopausal women compared to premenopausal women (6.5±1.13 versus 4.85±0.86, P<0.001) during Pipelle endometrial sampling. There was also a higher rate of tenaculum use and analgesic requirements with less adequacy of the sample and less acceptability in postmenopausal women (P<0.001).
CONCLUSIONS: Pipelle endometrial sampling is more painful, less adequate and less acceptable in postmenopausal women compared to premenopausal women with AUB. Further larger trials are needed to confirm these findings.

Entities:  

Mesh:

Year:  2016        PMID: 27430200

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  2 in total

1.  Endophytic-Type Endometrial Cancer with Adenomyosis Successfully Diagnosed with Hysteroscopic Endometrial Biopsy Using an 8.3-mm Operative Resectoscope: A Case Report.

Authors:  Michiko Honda; Akira Tsuchiya; Wataru Isono; Mikiko Takahashi; Akihisa Fujimoto; Masashi Kawamoto; Osamu Nishii
Journal:  Case Rep Oncol       Date:  2018-05-29

2.  Pipelle endometrial biopsy for abnormal uterine bleeding: do patient's pain and anxiety really impact on sampling success rate?

Authors:  Aiym Kaiyrlykyzy; Faina Linkov; Faye Foster; Gauri Bapayeva; Talshyn Ukybassova; Gulzhanat Aimagambetova; Kamila Kenbayeva; Bakytkali Ibrayimov; Alla Lyasova; Milan Terzic
Journal:  BMC Womens Health       Date:  2021-11-12       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.